Encorafenib
HealthData.Gov
Updated Mar 24, 2026
About this dataset
BRAFTOVI (encorafenib) is an oral prescription drug manufactured by Array BioPharma Inc., available as capsules in 75mg strength (50mg discontinued). Approved under NDA210496, it's used for certain cancers. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Encorafenib
Access the FDA dataset for Encorafenib — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025